TD Cowen on Astrana Health, Inc (ASTH): 'Execution on Track, Structural Differentiation Reinforced'

April 16, 2026 8:57 AM

TD Cowen analyst Jailendra Singh reiterated a Buy rating and $38.00 price target on Astrana Health, Inc (NASDAQ: ASTH).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found